What is Organon's gain/loss on asset sales?

Organon (OGN) reported gain/loss on asset sales of $81M in Q1 2026.

What does gain/loss on asset sales mean?

Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.

Organon OGN Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Opko HealthOPK

$34K-99.1%

PBH

Prestige Consumer HealthcarePBH

-$25K+83.4%

Bausch + LombBLCO

$3M—

ProgynyPGNY

-$52K+34.2%

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.54B+39.7%

Enterprise value$10.99B+0.5%

P/E6.6×+2.1×

P/S0.6×+0.2×

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's gain/loss on asset sales?: Organon (OGN) reported gain/loss on asset sales of $81M in Q1 2026.
What does gain/loss on asset sales mean?: Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.